> 5% of Cmax for endogenous molecule? [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-06-18 10:00 (2195 d 15:25 ago) – Posting: # 18913
Views: 4,058

Dear All,

As per guidelines, Subjects with non-zero baseline concentrations > 5% of Cmax. Such data should be excluded from bioequivalence calculation.

Is it applicable for endogenous molecule? could you please suggest anyone..



Regards,
Ramesh. R

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,663 registered users;
33 visitors (0 registered, 33 guests [including 6 identified bots]).
Forum time: 01:25 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5